Brighthouse Financial (BHF) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
14 Apr, 2026Voting matters and shareholder proposals
Nine directors nominated for election to serve one-year terms ending at the 2027 annual meeting.
Ratification of Deloitte & Touche LLP as independent registered public accounting firm for fiscal year 2026 is up for vote.
Advisory vote on executive compensation for named executive officers is included.
Board of directors and corporate governance
Board recommends voting in favor of all director nominees and proposals.
Director nominees include C. Edward Chaplin, Stephen C. Hooley, Michael J. Inserra, Carol D. Juel, Eileen A. Mallesch, Diane E. Offereins, Eric T. Steigerwalt, Paul M. Wetzel, and Lizabeth H. Zlatkus.
Executive compensation and say-on-pay
Advisory vote seeks shareholder approval of compensation paid to named executive officers.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Brighthouse Financial
- Q2 2026 net income hit $956M, with strong annuity sales and a pending $4.1B acquisition.BHF
Q2 2026 - All board-recommended proposals passed, including director elections and Say-on-Pay.BHF
AGM 2026 - Net loss widened to $792M, adjusted earnings rose, and the Aquarian merger remains on track.BHF
Q1 2026 - Pending merger, record sales, and strong governance define this year's proxy highlights.BHF
Proxy filing - Q4 net income declined, but record annuity and life sales and a pending $4.1B acquisition marked 2025.BHF
Q4 2025 - Merger and related proposals were approved by stockholders as recommended by the board.BHF
EGM 2026 - Shareholders to vote on merger amid litigation and board's unanimous support.BHF
Proxy Filing - Adjusted earnings surged on actuarial gains, with life sales up 19% and capital actions ongoing.BHF
Q3 2024 - Adjusted earnings reached $346M with record life sales, but statutory capital and RBC ratio declined.BHF
Q2 2024